We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Faster Telemetry Offered by New Defibrillators

By HospiMedica staff writers
Posted on 09 Jun 2006
New implantable devices for treating patients with potentially lethal heart arrhythmias and heart failure offer faster telemetry and other improved features.

The Epic II ICD (implantable cardioverter defibrillator) and the Epic II HF CRT-D (cardiac resynchronization therapy defibrillator) devices, made by St. More...
Jude Medical (St. Paul, MN, USA), feature faster telemetry that speeds data from the ICD to the system programmer at a rate up to five times faster than previous St. Jude devices. A vibrating patient notifier in each device issues a vibration instead of an audio alert to notify patients of critical changes in device performance. Both devices have been cleared by the U.S. Food and Drug Administration (FDA).

Other features include SenseAbility, a technology designed to allow optimizing of sensing parameters that may protect against inappropriate ICD shocks; autointrinsic conduction search (AICS), intended to promote more natural heart function and minimize ventricular pacing; and DeFT (defibrillation thresholds) response technology to help physicians manage patients who require higher levels of defibrillation.

"I was impressed with the speed of the new Epic II ICD device. Many things were noticeably faster, like the ability to download stored electrograms,” said Senthil Natarajan, M.D., of Rochester General Hospital (NY, USA). "The vibrating patient notifier, which is the industry's first non-audio alert, is especially helpful for those patients who have difficulty hearing and would typically rely on a family member to listen for an alert.”

An implantable cardioverter defibrillator is used in patients at risk for recurrent, sustained ventricular tachycardia or fibrillation. Cardiac resynchronization therapy (CRT)--delivered by an ICD or a pacemaker--resynchronizes the beating of the heart's ventricles, which often beat out of sync in heart-failure patients..


Related Links:
St. Jude Medical

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Needle Guide Disposable Kit
Verza
New
Mobile X-Ray Machine
MARS 15 / 30
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.